Pulse pressure reduction and cardiovascular protection

Area of Science:

• Cardiovascular Medicine
• Hypertension Research
• Pharmacology

Background:

• Brachial pulse pressure (PP) is a recognized cardiovascular risk factor.
• Central PP (carotid or ascending aorta) better reflects hemodynamic effects on target organs than peripheral PP.
• Central PP has independent predictive value for mortality in specific patient groups.

Purpose of the Study:

• To identify clinical characteristics predicting a fall in PP and cardiovascular events in hypertensive patients with type 2 diabetes.
• To evaluate the effectiveness of specific antihypertensive strategies in lowering central PP.
• To determine if lowering central PP translates to reduced cardiovascular events.

Main Methods:

• The PARADIS study investigated hypertensive patients with type 2 diabetes and PP > 60 mmHg.
• Analysis focused on clinical predictors of PP reduction and cardiovascular event decrease.
• Evaluation of a fixed low-dose perindopril/indapamide combination therapy.

Main Results:

• A fixed low-dose perindopril/indapamide combination effectively lowered central PP.
• This therapeutic strategy also led to a reduction in cardiovascular events.
• Effective PP lowering and event reduction were achieved under usual care conditions.

Conclusions:

• Central PP measurement is crucial for assessing antihypertensive agent efficacy.
• Specific therapeutic strategies, like perindopril/indapamide, can effectively manage central PP in diabetic hypertensives.
• Lowering central PP is a viable target for reducing cardiovascular events in this high-risk population.